PEGS Boston – virtual event

May 11-14, 2021
Virtual Event

Join YUMAB´s team at this year’s PEGS Boston Virtual to get the latest data on YUMAB’s fully human antibody technology platform and learn more about the company’s potential in fully human antibody engineering.

Don’t miss the panel discussion Novel and Next-Generation Approaches to COVID-19 Therapeutics” on May 11th at 10 a.m. GMT-4 (4 p.m. GMT+2), including the presentation “Novel Anti-SARS-CoV2 Antibody Therapy with Safety Design for Treatment of Moderate to Severe COVID-19” by YUMAB’s CEO Thomas Schirmann.

Arrange a meeting

Visit YUMAB’s virtual booth at the meeting, interact with the team and dowload infos to learn more about your options!
et us take you there:

People attending from YUMAB:

David Passmore, PhD
Business Development


Linda Kirchner, PhD
Head of Business & Finances

Alexander Ehm
Head of Global Business Development


Jonas Kügler, PhD
Head of Research & Technologies


Thomas Schirrmann, PhD
Founder & CEO